Neesgaard, B;
Mocroft, A;
Greenberg, L;
Larsen, JF;
Wandeler, G;
Zangerle, R;
Gunthard, H;
... Ryom, L; + view all
(2020)
How to RESPOND to Modern Challenges for People Living with HIV: A Profile for a New Cohort Consortium.
Microorganisms
, 8
(8)
, Article 1164. 10.3390/microorganisms8081164.
Preview |
Text
microorganisms-08-01164-v2.pdf - Published Version Download (1MB) | Preview |
Abstract
Background: the International Cohort Consortium of Infectious Disease (RESPOND) is a collaboration dedicated to research on HIV and other infectious diseases. Methods: RESPOND is a flexible organization, with several independent substudies operating under one shared governance. HIV-related variables, including full antiretroviral therapy (ART) history, are collected annually for all participants and merged with substudy specific data into a shared data pool. Incident clinical events are reported using standardized forms. Prospective follow-up started 1/10/17 (enrolment) with retrospective data collected back to 01/01/12. Results: Overall, 17 cohorts from Europe and Australia provided data on 26,258 people living with HIV (PLWH). The majority (43.3%) of the population were white, with men-sex-with-men accounting for 43.3% of the risk for HIV acquisition. The median age was 48 years (IQR 40–56) and 5.2% and 25.5% were known to be co-infected with hepatitis B or C. While 5.3% were ART-naïve, the median duration on ART was 10.1 years (4.8–17.6), with 89.5% having a VL <200 copies/mL and the median CD4 count being 621 cells/µL (438–830). Malignancies (n = 361) and cardiovascular disease (n = 168) were the predominant reported clinical events. Conclusion: RESPOND’s large, diverse study population and standardized clinical endpoints puts the consortium in a unique position to respond to the diverse modern challenges for PLWH.
Type: | Article |
---|---|
Title: | How to RESPOND to Modern Challenges for People Living with HIV: A Profile for a New Cohort Consortium |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.3390/microorganisms8081164 |
Publisher version: | https://doi.org/10.3390/microorganisms8081164 |
Language: | English |
Additional information: | This is an open access article distributed under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
Keywords: | HIV; cohort; observational study; hepatitis; public health; tuberculosis; pharmacovigilance |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health > Infection and Population Health |
URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10110516 |
Archive Staff Only
![]() |
View Item |